Drugs Approved for Bladder Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for bladder cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in bladder cancer that are not listed here.
Drugs Approved for Bladder Cancer
- Adstiladrin (Nadofaragene Firadenovec-vncg)
- Anktiva (Nogapendekin Alfa Inbakicept-pmln)
- Avelumab
- Balversa (Erdafitinib)
- Bavencio (Avelumab)
- Cisplatin
- Doxorubicin Hydrochloride
- Durvalumab
- Enfortumab Vedotin-ejfv
- Erdafitinib
- Imfinzi (Durvalumab)
- Jelmyto (Mitomycin)
- Keytruda (Pembrolizumab)
- Mitomycin
- Nadofaragene Firadenovec-vncg
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Nogapendekin Alfa Inbakicept-pmln
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Padcev (Enfortumab Vedotin-ejfv)
- Pemazyre (Pemigatinib)
- Pembrolizumab
- Pemigatinib
- Tepadina (Thiotepa)
- Thiotepa
- Valrubicin
- Valstar (Valrubicin)
Drug Combinations Used in Bladder Cancer